Christopher Lee is an associate in the Orange County office of Gibson, Dunn & Crutcher, where he currently practices in the firm’s Corporate Department. His practice focuses on mergers and acquisitions, and his experience includes representation of public and private companies in general corporate governance matters and complex business transactions.

He received his juris doctor degree from Yale Law School and served as a teaching assistant for Corporate Finance at the Yale School of Management. Christopher graduated cum laude  from Yale University with a bachelor’s degree in political science with distinction.

His experience includes representation of:*

• A publicly traded biopharmaceutical company in its US$6.5 billion sale to a global biopharmaceutical company
• A publicly traded high-technology sensors solutions company in its US$1.7 billion acquisition of a publicly traded test systems and sensors company and subsequent US$700 million sale of a division of that company
• A publicly traded biotechnology company in its US$2.7 billion acquisition of a 20.5% stake in a publicly traded biotechnology company
• A publicly traded homebuilding company in its US$2.5 billion sale to a publicly traded homebuilding company
• A publicly traded healthcare company in connection with its US$4.9 billion sale of a business segment
• A virtual behavioral health company in its US$1.4 billion deSPAC merger
• A global asset manager in its acquisition of a real estate asset manager managing over US$100 billion in assets
• A publicly traded biopharmaceutical company in its US$1.5 billion acquisition of products from a global pharmaceutical company
• A buyer consortium in its US$1.1 billion acquisition of a publicly traded internet content and marketing service provider

* Includes matters handled prior to joining Gibson, Dunn & Crutcher

Prior to joining Gibson Dunn, Chris practiced with Latham & Watkins. He is admitted to practice in California.